Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes

被引:85
作者
McIntosh, LJ
Trush, MA
Troncoso, JC
机构
[1] JOHNS HOPKINS MED INST, SCH HYG & PUBL HLTH, DEPT ENVIRONM HLTH SCI, BALTIMORE, MD 21205 USA
[2] JOHNS HOPKINS MED INST, SCH MED, DEPT PATHOL, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA
[3] JOHNS HOPKINS MED INST, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; lipid peroxidation; chemiluminescence; vitamin E; temporal cortex;
D O I
10.1016/S0891-5849(96)00573-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reactive oxygen-mediated processes are thought to contribute to the pathogenesis of Alzheimer's disease (AD). To investigate this hypothesis we studied autopsy tissue from Il pairs of AD cases and control individuals matched for age, postmortem delay, and tissue storage time. The temporal neocortex, which is severely involved by AD pathology, and the cerebellum, which is spared, were analyzed for tissue markers of lipid peroxidation (LPO). The average chemiluminescence formed from bond breakage in tissue homogenates during a 3-h incubation, without the presence of catalysts such as metal ions or ascorbate, was significantly increased in the AD temporal cortex to 130% of matched controls. Basal tissue content of LPO products (thiobarbituric acid reactive substances-TBARs) was not different between groups. However, TBARs were significantly elevated in AD temporal cortex to 135% of control after the incubation. In contrast, in the cerebellum there was no difference between AD and control tissue, indicating a disease-specific tissue effect. Because the use of oral antioxidants have received considerable attention in the last few years, the results seen in the testing of an AD patient who took daily vitamin E supplements for 4 years is particularly interesting. The time course for CL reactivity in the temporal cortex was considerably delayed compared to all other samples. This observation is consistent with the hypothesis that antioxidants within tissue will quench ROS-mediated reactions. This study indicates that there is increased susceptibility to ROS in the AD temporal cortex that may contribute to the pathogenesis of the disease. Furthermore, our observations suggest that oral antioxidant supplementation may be protective against LPO in the human brain. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:183 / 190
页数:8
相关论文
共 41 条
[21]   MITOCHONDRIA FROM ALZHEIMERS FIBROBLASTS SHOW DECREASED UPTAKE OF CALCIUM AND INCREASED SENSITIVITY TO FREE-RADICALS [J].
KUMAR, U ;
DUNLOP, DM ;
RICHARDSON, JS .
LIFE SCIENCES, 1994, 54 (24) :1855-1860
[22]   ELEVATION IN RELATIVE LEVELS OF BRAIN MEMBRANE UNSATURATED FATTY-ACIDS IN ALZHEIMERS-DISEASE - HIGH-RESOLUTION PROTON SPECTROSCOPIC STUDIES OF MEMBRANE LIPID EXTRACTS [J].
KWEE, IL ;
NAKADA, T ;
ELLIS, WG .
MAGNETIC RESONANCE IN MEDICINE, 1991, 21 (01) :49-54
[23]   CERULOPLASMIN IS INCREASED IN CEREBROSPINAL-FLUID IN ALZHEIMERS-DISEASE BUT NOT PARKINSONS-DISEASE [J].
LOEFFLER, DA ;
DEMAGGIO, AJ ;
JUNEAU, PL ;
BRICKMAN, CM ;
MASHOUR, GA ;
FINKELMAN, JH ;
POMARA, N ;
LEWITT, PA .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1994, 8 (03) :190-197
[24]   SUPEROXIDE-DISMUTASE ISOENZYMES IN NORMAL BRAINS AND IN BRAINS FROM PATIENTS WITH DEMENTIA OF ALZHEIMER TYPE [J].
MARKLUND, SL ;
ADOLFSSON, R ;
GOTTFRIES, CG ;
WINBLAD, B .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1985, 67 (03) :319-325
[25]   DIFFERENT AMYLOIDOGENIC PEPTIDES SHARE A SIMILAR MECHANISM OF NEUROTOXICITY INVOLVING REACTIVE OXYGEN SPECIES AND CALCIUM [J].
MATTSON, MP ;
GOODMAN, Y .
BRAIN RESEARCH, 1995, 676 (01) :219-224
[26]   OXIDATIVE DAMAGE TO MITOCHONDRIAL-DNA IS INCREASED IN ALZHEIMERS-DISEASE [J].
MECOCCI, P ;
MACGARVEY, U ;
BEAL, MF .
ANNALS OF NEUROLOGY, 1994, 36 (05) :747-751
[27]   VITAMIN-E CONCENTRATIONS IN HUMAN BRAIN OF PATIENTS WITH ALZHEIMERS-DISEASE, FETUSES WITH DOWNS-SYNDROME, CENTENARIANS, AND CONTROLS [J].
METCALFE, T ;
BOWEN, DM ;
MULLER, DPR .
NEUROCHEMICAL RESEARCH, 1989, 14 (12) :1209-1212
[28]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE [J].
MIRRA, SS ;
HEYMAN, A ;
MCKEEL, D ;
SUMI, SM ;
CRAIN, BJ ;
BROWNLEE, LM ;
VOGEL, FS ;
HUGHES, JP ;
VANBELLE, G ;
BERG, L .
NEUROLOGY, 1991, 41 (04) :479-486
[29]   EVIDENCE FOR A MEMBRANE DEFECT IN ALZHEIMER-DISEASE BRAIN [J].
NITSCH, RM ;
BLUSZTAJN, JK ;
PITTAS, AG ;
SLACK, BE ;
GROWDON, JH ;
WURTMAN, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) :1671-1675
[30]   SELECTIVE INCREASE IN LIPID-PEROXIDATION IN THE INFERIOR TEMPORAL CORTEX IN ALZHEIMERS-DISEASE [J].
PALMER, AM ;
BURNS, MA .
BRAIN RESEARCH, 1994, 645 (1-2) :338-342